2016 INNOVATE MONTANA SYMPOSIUM PANELIST
Jay Evans served as a featured panelist at the 2016 Innovate Montana Symposium on July 13th & 14th in Billings, MT. Jay is the CEO of Inimmune and the Director of the Center for Transitional Medicine at the University of Montana. He shared his insights and ideas on overcoming obstacles and anticipating change in business and industry.
Dr. Evans is the President and CEO of Inimmune Corp., a biotech company in Missoula, MT focused on the discovery and development of new immunomodulatory therapeutics. Jay is also Research Professor in the Division of Biological Sciences and Director of the Center for Translational Medicine at the University of Montana. Prior to joining the University of Montana, Dr. Evans worked in the biotechnology and pharmaceutical industry for 15 years at GlaxoSmithKline Vaccines (formerly Corixa Corporation and Ribi ImmunoChem). While at GSK Vaccines, Dr. Evans worked on the discovery and development of novel vaccines, adjuvants and immunotherapeutics. Dr. Evans completed is Postdoctoral Fellowship at the University of Texas Southwestern Medical Center and St. Jude Children’s Research Hospital working HIV immunology, stem cell transplantation and vector-based gene therapy systems. Dr. Evans holds a Ph.D. in Molecular and Cellular Biology from Oregon State University and a B.S. in Biology from Pacific Lutheran University.
Jay was raised in the Northwest where he developed an appreciation for science and a love of the outdoors. After completing a postdoctoral fellowship in Tennessee and Texas he moved to the Bitterroot Valley in Western Montana to raise his family and work in the biotechnology industry while enjoying the vast outdoor recreational opportunities Montana has to offer. In January of 2016, Jay and a team of talented scientists from GlaxoSmithKline Vaccines (Hamilton, MT) moved their research program to the University of Montana and started a new biotechnology company in Missoula (Inimmune Corp).
Jay is married to Cindy Evans and has three kids (Tyler, Kaylee and Cole). In his free time Jay and enjoys spending time with his family camping, fishing, hiking, hunting and enjoying the Montana outdoors.
Inimmune is a biotech company in Missoula, MT focused on the discovery and development of new immunomodulatory therapeutics for treatment of Allergic Diseases, Upper Respiratory Tract Infection, Topical Treatment of Skin Diseases and other diseases targeted through innate immune receptor activation or inhibition. Inimmune will also provide fee-based contract services to pharmaceutical industry partners in support of ongoing R&D and Manufacturing Operations. Inimmune is strongly affiliated with the University of Montana and will seek to commercialize technologies from a newly formed cross-functional Center for Translational Medicine at the University. The Inimmune management team includes 5 Ph.D. scientists from GSK Vaccines with over 70 years combined biotech and pharmaceutical industry experience along with highly experienced scientific and technical staff.